Providers who e-prescribe birth control through apps and online pharmacies doubt the decision will significantly affect their practices, but they say the mandate is harmful for those who need contraception.
The U.S. Department of Health and Human Services also announced it would give $450 million to the biotech company Regeneron to manufacture and supply the company’s antibody treatment.